Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia

Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia

Background: Chinese medicine (CM) is widely used for treating hyperlipidemias, especially in China. However, the heterogeneity of outcomes measured and reported across trials exacerbates the obstacles of evidence synthesis and effectiveness comparison. In this study, we develop a core outcome set (C...

Full description

Bibliographic Details
Main Authors: Geng Li, Ruxue Han, Mingjun Lin, Zehuai Wen, Xiankun Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
hyperlipidemia
core outcome set
Chinese medicine
systematic review
delphi survey
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.847101/full

Similar Items

Similar Items